Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD

ClinicalTrials.gov ID: NCT03763318

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03763318. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 10:41 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of EQ001 in Subjects With Newly Diagnosed Acute Graft Versus Host Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center study to evaluate the safety, tolerability, PK, PD, and clinical activity of EQ001 in subjects with Acute Graft Versus Host Disease (aGVHD).

Study identification

NCT ID
NCT03763318
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Biocon Limited
Industry
Enrollment
30 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 15, 2019 (Actual)
Primary completion
Nov 21, 2022 (Actual)
Completion
Nov 21, 2022 (Actual)
Last update posted
Jun 11, 2026

2019 – 2022

United States locations

U.S. sites
16
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
City of Hope Comprehensive Cancer Center Duarte California 91010 —
University of Florida Health Shands Hospital Gainesville Florida 32610 —
University of Miami - Miller School of Medicine Miami Florida 33136 —
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612 —
Emory University Hospital Atlanta Georgia 30322 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
University of Michigan - C.S. Mott Children's Hospital Ann Arbor Michigan 48109 —
Washington University and Barnes Jewish Heart & Vascular Center St Louis Missouri 63110 —
Roswell Park Cancer Institute Buffalo New York 14263 —
University of North Carolina Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 —
Oregon Health & Science University Portland Oregon 97239 —
University of Pennsylvania, Abramson Cancer Center Philadelphia Pennsylvania 19104 —
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15232 —
TriStar Centennial Medical Center (SCRI) Nashville Tennessee 53719 —
Intermountain Healthcare Salt Lake City Utah 84103 —
Fred Hutchinson Cancer Research Center Seattle Washington 98109-4433 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03763318, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 11, 2026 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.